001     136892
005     20240321220144.0
024 7 _ |a 10.1523/JNEUROSCI.3372-12.2013
|2 doi
024 7 _ |a pmid:23637177
|2 pmid
024 7 _ |a pmc:PMC6618983
|2 pmc
024 7 _ |a 0270-6474
|2 ISSN
024 7 _ |a 1529-2401
|2 ISSN
024 7 _ |a altmetric:41312032
|2 altmetric
037 _ _ |a DZNE-2020-03214
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Fleck, Daniel
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling.
260 _ _ |a Washington, DC
|c 2013
|b Soc.57413
264 _ 1 |3 online
|2 Crossref
|b Society for Neuroscience
|c 2013-05-01
264 _ 1 |3 print
|2 Crossref
|b Society for Neuroscience
|c 2013-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1589983214_10887
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Proteolytic shedding of cell surface proteins generates paracrine signals involved in numerous signaling pathways. Neuregulin 1 (NRG1) type III is involved in myelination of the peripheral nervous system, for which it requires proteolytic activation by proteases of the ADAM family and BACE1. These proteases are major therapeutic targets for the prevention of Alzheimer's disease because they are also involved in the proteolytic generation of the neurotoxic amyloid β-peptide. Identification and functional investigation of their physiological substrates is therefore of greatest importance in preventing unwanted side effects. Here we investigated proteolytic processing of NRG1 type III and demonstrate that the ectodomain can be cleaved by three different sheddases, namely ADAM10, ADAM17, and BACE1. Surprisingly, we not only found cleavage by ADAM10, ADAM17, and BACE1 C-terminal to the epidermal growth factor (EGF)-like domain, which is believed to play a pivotal role in signaling, but also additional cleavage sites for ADAM17 and BACE1 N-terminal to that domain. Proteolytic processing at N- and C-terminal sites of the EGF-like domain results in the secretion of this domain from NRG1 type III. The soluble EGF-like domain is functionally active and stimulates ErbB3 signaling in tissue culture assays. Moreover, the soluble EGF-like domain is capable of rescuing hypomyelination in a zebrafish mutant lacking BACE1. Our data suggest that NRG1 type III-dependent myelination is not only controlled by membrane-retained NRG1 type III, but also in a paracrine manner via proteolytic liberation of the EGF-like domain.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
542 _ _ |i 2013-11-01
|2 Crossref
|u https://creativecommons.org/licenses/by-nc-sa/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a NRG3 protein, human
|2 NLM Chemicals
650 _ 7 |a Neuregulins
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a RNA, Small Interfering
|2 NLM Chemicals
650 _ 7 |a Epidermal Growth Factor
|0 62229-50-9
|2 NLM Chemicals
650 _ 7 |a Amyloid Precursor Protein Secretases
|0 EC 3.4.-
|2 NLM Chemicals
650 _ 7 |a Aspartic Acid Endopeptidases
|0 EC 3.4.23.-
|2 NLM Chemicals
650 _ 7 |a BACE1 protein, human
|0 EC 3.4.23.46
|2 NLM Chemicals
650 _ 7 |a ADAM Proteins
|0 EC 3.4.24.-
|2 NLM Chemicals
650 _ 7 |a ADAM17 Protein
|0 EC 3.4.24.86
|2 NLM Chemicals
650 _ 7 |a ADAM17 protein, human
|0 EC 3.4.24.86
|2 NLM Chemicals
650 _ 7 |a Adam17 protein, rat
|0 EC 3.4.24.86
|2 NLM Chemicals
650 _ 2 |a ADAM Proteins: metabolism
|2 MeSH
650 _ 2 |a ADAM17 Protein
|2 MeSH
650 _ 2 |a Amyloid Precursor Protein Secretases: metabolism
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Aspartic Acid Endopeptidases: metabolism
|2 MeSH
650 _ 2 |a Cell Membrane: metabolism
|2 MeSH
650 _ 2 |a Cells, Cultured
|2 MeSH
650 _ 2 |a Cricetinae
|2 MeSH
650 _ 2 |a Cricetulus
|2 MeSH
650 _ 2 |a Embryo, Mammalian
|2 MeSH
650 _ 2 |a Epidermal Growth Factor: analogs & derivatives
|2 MeSH
650 _ 2 |a Epidermal Growth Factor: chemistry
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Immunoprecipitation
|2 MeSH
650 _ 2 |a Neuregulins: genetics
|2 MeSH
650 _ 2 |a Neuregulins: metabolism
|2 MeSH
650 _ 2 |a Neurons
|2 MeSH
650 _ 2 |a Paracrine Communication: physiology
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Proteolysis
|2 MeSH
650 _ 2 |a RNA, Messenger: administration & dosage
|2 MeSH
650 _ 2 |a RNA, Messenger: metabolism
|2 MeSH
650 _ 2 |a RNA, Small Interfering: metabolism
|2 MeSH
650 _ 2 |a Rats
|2 MeSH
650 _ 2 |a Rats, Sprague-Dawley
|2 MeSH
650 _ 2 |a Schwann Cells
|2 MeSH
650 _ 2 |a Transfection
|2 MeSH
650 _ 2 |a Zebrafish
|2 MeSH
700 1 _ |a van Bebber, Frauke
|0 P:(DE-2719)9000319
|b 1
700 1 _ |a Colombo, Alessio
|0 P:(DE-2719)2340744
|b 2
700 1 _ |a Galante, Chiara
|b 3
700 1 _ |a Schwenk, Benjamin M
|0 P:(DE-2719)2551184
|b 4
700 1 _ |a Rabe, Linnea
|b 5
700 1 _ |a Hampel, Heike
|b 6
700 1 _ |a Novak, Bozidar
|b 7
700 1 _ |a Kremmer, Elisabeth
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Tahirovic, Sabina
|0 P:(DE-2719)2442036
|b 9
700 1 _ |a Edbauer, Dieter
|0 P:(DE-2719)2231621
|b 10
700 1 _ |a Lichtenthaler, Stefan F
|0 P:(DE-2719)2181459
|b 11
700 1 _ |a Schmid, Bettina
|0 P:(DE-2719)2241638
|b 12
700 1 _ |a Willem, Michael
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Haass, Christian
|0 P:(DE-2719)2202037
|b 14
|e Last author
773 1 8 |a 10.1523/jneurosci.3372-12.2013
|b Society for Neuroscience
|d 2013-05-01
|n 18
|p 7856-7869
|3 journal-article
|2 Crossref
|t The Journal of Neuroscience
|v 33
|y 2013
|x 0270-6474
773 _ _ |a 10.1523/JNEUROSCI.3372-12.2013
|g Vol. 33, no. 18, p. 7856 - 7869
|0 PERI:(DE-600)1475274-8
|n 18
|q 33:18<7856 - 7869
|p 7856-7869
|t The journal of neuroscience
|v 33
|y 2013
|x 0270-6474
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618983
909 C O |p VDB
|o oai:pub.dzne.de:136892
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000319
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2340744
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2551184
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2442036
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2231621
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2181459
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2241638
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2202037
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2013
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROSCI : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROSCI : 2017
920 1 _ |0 I:(DE-2719)1140002
|k Zebrafish Models ; AG Schmid ; AG Schmid München
|l Zebrafish Models
|x 0
920 1 _ |0 I:(DE-2719)1110006
|k AG Lichtenthaler
|l Neuroproteomics
|x 1
920 1 _ |0 I:(DE-2719)1110004
|k AG Edbauer
|l Cell Biology of Neurodegeneration
|x 2
920 1 _ |0 I:(DE-2719)1140003
|k AG Tahirovic
|l Ex vivo models
|x 3
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass old
|l ALS, FTLD and Zebrafish models
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1140002
980 _ _ |a I:(DE-2719)1110006
980 _ _ |a I:(DE-2719)1110004
980 _ _ |a I:(DE-2719)1140003
980 _ _ |a I:(DE-2719)5000015
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1083/jcb.200212085
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nn1342
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/glia.20753
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/385729a0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.yexcr.2008.10.011
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.neuron.2008.06.028
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0092-8674(00)80675-3
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1042/BJ20090549
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.8424174
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M003202200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1523/JNEUROSCI.0605-10.2010
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/360672a0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/0896-6273(95)90323-2
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nrneurol.2009.218
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/1559-0275-8-9
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1083/jcb.139.6.1495
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1023/B:NEUR.0000020614.83883.be
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/sj.emboj.7600061
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.ydbio.2005.05.004
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nn1797
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1096/fj.08-106666
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Karey
|y 1988
|2 Crossref
|o Karey 1988
999 C 5 |a 10.1002/aja.1002030302
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/0092-8674(86)90841-X
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1152/physiol.00028.2010
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nn.2849
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/j.1471-4159.2011.07248.x
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.2174/1386207053258488
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M111.251538
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nrn2392
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.1095862
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.conb.2009.08.006
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1006/mcne.2000.0896
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/glia.21260
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.semcdb.2010.08.008
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1093/emboj/cdf541
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/embor.2012.90
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1242/dev.068072
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1080/08977190600634373
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1093/embo-reports/kve180
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M007913200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1523/JNEUROSCI.1681-09.2010
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.neuron.2005.08.017
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/emboj.2012.42
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/jnc.12198
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/alzrt82
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/glia.21255
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M005700200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1074/jbc.M601542200
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1126/science.1132341
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0896-6273(00)80873-9
|9 -- missing cx lookup --
|2 Crossref


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21